[HTML][HTML] Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients
S Blitshteyn, S Whitelaw - Immunologic research, 2021 - Springer
Immunologic research, 2021•Springer
Objective To describe clinical features, diagnostic findings, treatments, and outcomes in
patients with new-onset postural orthostatic tachycardia syndrome (POTS) and other
autonomic disorders following SARS-CoV-2 infection (COVID-19). Methods We
retrospectively reviewed medical records for patients who presented with persistent
neurologic and cardiovascular complaints between April and December 2020 following
COVID-19 infection. Results Twenty patients (70% female) were included in this study …
patients with new-onset postural orthostatic tachycardia syndrome (POTS) and other
autonomic disorders following SARS-CoV-2 infection (COVID-19). Methods We
retrospectively reviewed medical records for patients who presented with persistent
neurologic and cardiovascular complaints between April and December 2020 following
COVID-19 infection. Results Twenty patients (70% female) were included in this study …
Abstract
Objective
To describe clinical features, diagnostic findings, treatments, and outcomes in patients with new-onset postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders following SARS-CoV-2 infection (COVID-19).
Methods
We retrospectively reviewed medical records for patients who presented with persistent neurologic and cardiovascular complaints between April and December 2020 following COVID-19 infection.
Results
Twenty patients (70% female) were included in this study. Fifteen had POTS, 3 had neurocardiogenic syncope, and 2 had orthostatic hypotension. Six patients had abnormalities on cardiac or pulmonary testing, and 4 had elevated autoimmune or inflammatory markers. All patients were treated with non-pharmacologic therapies, and most required pharmacologic therapies. Six to 8 months after COVID-19, 17 (85%) patients had residual autonomic symptoms, with 12 (60%) unable to return to work.
Conclusions
POTS can follow COVID-19 in previously healthy patients. Appropriate diagnostic investigations and therapies are necessary to identify and treat autonomic dysfunction after COVID-19.
Springer
